New cancer gel targets rare urinary tract tumors without surgery
Disease control
Recruiting now
This study tests a new version of a cancer drug called UGN-104, given directly into the upper urinary tract, for people with low-grade upper tract urothelial cancer. The goal is to see if it can completely eliminate visible tumors and keep the cancer from coming back. About 70 ad…
Phase: PHASE3 • Sponsor: UroGen Pharma Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC